GWAS has been recently used to identify new genetic biomarkers associated with the differential response to anti-TNF agents (Liu et al., 2008; Umicevic Mirkov et al., 2013; Honne et al., 2016; Julia et al., 2016), and only two studies were performed in psoriasis. The gene discussed is TNF; the disease is psoriasis.